Safety and feasibility of an early ambulation protocol after transfemoral transcatheter aortic valve implantation: results of the early mobilisation after TF-TAVI (MobiTAVI) trial

Back

ESC Premium Access

Safety and feasibility of an early ambulation protocol after transfemoral transcatheter aortic valve implantation: results of the early mobilisation after TF-TAVI (MobiTAVI) trial

Session: Advances in structural heart interventions

Topic: Aortic Valve Intervention

Speaker: Mr J. Vendrik (Amsterdam, NL)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Mr Jeroen Vendrik

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))

0 follower

5 more presentations in this session

The impact of residual mitral valve regurgitation on outcome after MitraClip therapy

Speaker: Doctor D. Reichart (Munich, DE)

Access

Abstract

Assessment of long-term structural deterioration of transcatheter aortic bioprosthetic valves using standardized new european definitions, a multicenter study

Speaker: Doctor A. Sokoloff (Rouen, FR)

6 month follow up results from the european transcatheter tricuspid valve repair multicenter trial

Speaker: Assistant Professor R. von Bardeleben (Mainz, DE)

Up to two-year outcomes from the multicenter CE trial of transcatheter mitral valve repair in patients with functional mitral regurgitation

Speaker: Doctor A. Latib (New York, US)

Panel discussion.

Access

Video

Access the full session

Advances in structural heart interventions

Speakers: Mr J. Vendrik, Doctor D. Reichart, Doctor A. Sokoloff, Assistant Professor R. von Bardeleben, Doctor A. Latib

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources